IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment.

Although insulin-like growth factor-I (IGF-I) can act as a neurotrophic factor for peripheral neurons in vitro and in vivo following injury, the role IGF-I plays during normal development and functioning of the peripheral nervous system is unclear. Here, we report that transgenic mice with reduced levels (two genotypes: heterozygous Igf1+/- or homozygous insertional mutant Igf1m/m) or totally lacking IGF-I (homozygous Igf1-/-) show a decrease in motor and sensory nerve conduction velocities in vivo. In addition, A-fiber responses in isolated peroneal nerves from Igf1+/- and Igf1-/- mice are impaired. The nerve function impairment is most profound in Igf1-/- mice. Histopathology of the peroneal nerves in Igf1-/- mice demonstrates a shift to smaller axonal diameters but maintains the same total number of myelinated fibers as Igf1+/+ mice. Comparisons of myelin thickness with axonal diameter indicate that there is no significant reduction in peripheral nerve myelination in IGF-I-deficient mice. In addition, in Igf1m/m mice with very low serum levels of IGF-I, replacement therapy with exogenous recombinant hIGF-I restores both motor and sensory nerve conduction velocities. These findings demonstrate not only that IGF-I serves an important role in the growth and development of the peripheral nervous system, but also that systemic IGF-I treatment can enhance nerve function in IGF-I-deficient adult mice.

[1]  J. Crawley,et al.  Biochemical and Morphometric Analyses Show that Myelination in the Insulin-like Growth Factor 1 Null Brain Is Proportionate to Its Neuronal Composition , 1998, The Journal of Neuroscience.

[2]  E. Feldman,et al.  Insulin‐like growth factor‐I (IGF‐I) and IGF binding protein‐5 in Schwann cell differentiation , 1997, Journal of cellular physiology.

[3]  N. Omawari,et al.  Aminoguanidine‐effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin‐diabetic rats , 1997, British journal of pharmacology.

[4]  P. Distefano,et al.  Neurotrophin-3 Administration Attenuates Deficits of Pyridoxine-Induced Large-Fiber Sensory Neuropathy , 1997, The Journal of Neuroscience.

[5]  J. Ross,et al.  Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. , 1996, The Journal of clinical investigation.

[6]  C. Stewart,et al.  Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. , 1996, Physiological reviews.

[7]  E. Froesch,et al.  Insulin-like growth factor I: physiology, metabolic effects and clinical uses. , 1996, Diabetes/metabolism reviews.

[8]  G. Biessels,et al.  Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes , 1996, Journal of Neurological Sciences.

[9]  M. Sliwkowski,et al.  Establishment of Schwann cell lines from normal adult and embryonic rat dorsal root ganglia , 1996, Journal of Neuroscience Methods.

[10]  R. Mirsky,et al.  Regulation of Rat Schwann Cell Po Expression and DNA Synthesis by Insulin‐like Growth Factors In Vitro , 1996, The European journal of neuroscience.

[11]  D. Yee,et al.  Characterization of Insulin‐Like Growth Factor‐I and Its Receptor and Binding Proteins in Transected Nerves and Cultured Schwann Cells , 1996, Journal of neurochemistry.

[12]  P. Contreras,et al.  Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice. , 1995, The Journal of pharmacology and experimental therapeutics.

[13]  H. Phillips,et al.  Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy , 1995, Annals of neurology.

[14]  F. Hefti,et al.  Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons , 1995, Neuron.

[15]  I. Jung-Testas,et al.  Actions of steroid hormones and growth factors on glial cells of the central and peripheral nervous system , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  M. E. Lewis,et al.  Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. , 1993, Journal of neurobiology.

[17]  L. Powell-Braxton,et al.  IGF-I is required for normal embryonic growth in mice. , 1993, Genes & development.

[18]  M. E. Lewis,et al.  Insulin-like Growth Factor-I: Potential for Treatment of Motor Neuronal Disorders , 1993, Experimental Neurology.

[19]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[20]  W. Lee,et al.  Patterns of Insulin‐like Growth Factor and IGF Receptor Gene Expression in the Brain: Functional Implications , 1993, Annals of the New York Academy of Sciences.

[21]  R. Roth,et al.  Insulin receptor-related receptor messenger ribonucleic acid is focally expressed in sympathetic and sensory neurons and renal distal tubule cells. , 1993, Endocrinology.

[22]  P. Fernyhough,et al.  Insulin and insulin-like growth factor I enhance regeneration in cultured adult rat sensory neurones , 1993, Brain Research.

[23]  M. Carson,et al.  Insulin-like growth factor I increases brain growth and central nervous system myelination in tTransgenic mice , 1993, Neuron.

[24]  N. Inestrosa,et al.  Nerve regeneration is improved by insulin-like growth factor I (IGF-I) and basic flbroblast growth factor (bFGF). , 1993, Restorative neurology and neuroscience.

[25]  D. Ishii,et al.  Insulin-like growth factor II stimulates motor nerve regeneration. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Lee,et al.  Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  G. Wieneke,et al.  Hypoxic neuropathy versus diabetic neuropathy An electrophysiological study in rats , 1992, Journal of the Neurological Sciences.

[28]  D. Munoz,et al.  Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro , 1992, Journal of the Neurological Sciences.

[29]  H. Werner,et al.  Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: Comparison with insulin-like growth factors I and II , 1992, Neuroscience.

[30]  M. Hatten,et al.  Cerebellar granule cell neurogenesis is regulated by cell-cell interactions in vitro , 1991, Neuron.

[31]  A. Efstratiadis,et al.  A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting , 1990, Nature.

[32]  P. Caroni,et al.  Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors , 1990, The Journal of cell biology.

[33]  G. Lundborg,et al.  Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve , 1989, Brain Research.

[34]  M. Kanje,et al.  Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve , 1989, Brain Research.

[35]  Mark J. Brown,et al.  Influence of malnutrition on developing rat peripheral nerves , 1988, Experimental Neurology.

[36]  R. Clark,et al.  Growth promoting activity of IGF-I in the rat. , 1988, Acta paediatrica Scandinavica. Supplement.

[37]  W. Gispen,et al.  Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats. , 1987, Toxicology and applied pharmacology.

[38]  M. Rechler,et al.  Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  W. Daughaday,et al.  A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. , 1957, The Journal of laboratory and clinical medicine.